Surgery Partners receives ‘buy’ rating — 5 key notes

Nine analysts gave Nashville, Tenn.-based Surgery Partners a “buy” rating, according to The Cerbat Gem.

Advertisement

Here are five key notes:

1. The analysts have an average 12-month price target of $20.86.

2. On Jan. 17, 2017, Jeffries Group gave the company a $24 price target.

3. Surgery Partners opened Jan. 19, 2017, trading at $18 per share.

4. The company’s market cap. totals $872.87 million.

5. The P/E ratio is 92.78.

More articles on surgery centers:
Christ Hospital’s dispute with St. Elizabeth Healthcare over $24M ASC may wage on for years
Auburn Planning Board to consider surgery center application: 5 things to know
Massachusetts Department of Public Health updates DON regulations for existing freestanding ASCs: 4 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.